Cargando…

P2X7 receptor regulates osteoclast function and bone loss in a mouse model of osteoporosis

Post-menopausal osteoporosis is a condition that affects millions worldwide and places a huge socio-economic burden on society. Previous research has shown an association of loss of function SNPs in the gene for the purinergic receptor P2X7R with low bone mineral density, increased rates of bone los...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ning, Agrawal, Ankita, Jørgensen, Niklas Rye, Gartland, Alison
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823935/ https://www.ncbi.nlm.nih.gov/pubmed/29472582 http://dx.doi.org/10.1038/s41598-018-21574-9

Ejemplares similares

Human P2X7 Receptor Causes Cycle Arrest in RPMI-8226 Myeloma Cells to Alter the Interaction with Osteoblasts and Osteoclasts
por: Agrawal, Ankita, et al.
Publicado: (2020)

Absence of P2Y(2) Receptor Does Not Prevent Bone Destruction in a Murine Model of Muscle Paralysis-Induced Bone Loss
por: Agrawal, Ankita, et al.
Publicado: (2022)

The P2X7 Receptor: A Key Player in Immune-Mediated Bone Loss?
por: Kvist, Torben Madsen, et al.
Publicado: (2014)

Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women
por: Gartland, Alison, et al.
Publicado: (2012)

Genetic Background Strongly Influences the Bone Phenotype of P2X7 Receptor Knockout Mice
por: Syberg, Susanne, et al.
Publicado: (2012)

The role of the P2X7 receptor on bone loss in a mouse model of inflammation-mediated osteoporosis
por: Kvist, T.M., et al.
Publicado: (2015)

Association between P2X7 Receptor Polymorphisms and Bone Status in Mice
por: Syberg, Susanne, et al.
Publicado: (2012)

mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis
por: Hiraiwa, Manami, et al.
Publicado: (2019)

Purinergic signalling in bone
por: Rumney, Robin M. H., et al.
Publicado: (2012)

Association of P2X(7) receptor polymorphisms with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients
por: Wesselius, A., et al.
Publicado: (2012)

The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men
por: Schwarz, Peter, et al.
Publicado: (2011)

Osteoclast-mediated bone loss observed in a COVID-19 mouse model
por: Awosanya, Olatundun D., et al.
Publicado: (2022)

C‐terminal variants of the P2X7 receptor are associated with prostate cancer progression and bone metastasis – evidence from clinical and pre‐clinical data
por: Song, Haiping, et al.
Publicado: (2022)

Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy
por: Yang, Yeon-Suk, et al.
Publicado: (2020)

The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review
por: Xu, Jie, et al.
Publicado: (2023)

Rutin Improves Bone Histomorphometric Values by Reduction of Osteoclastic Activity in Osteoporosis Mouse Model Induced by Bilateral Ovariectomy
por: Lee, Hye-Hwa, et al.
Publicado: (2020)

Loss of menin in osteoblast lineage affects osteocyte–osteoclast crosstalk causing osteoporosis
por: Liu, Peng, et al.
Publicado: (2017)

Acacetin Prevents Bone Loss by Disrupting Osteoclast Formation and Promoting Type H Vessel Formation in Ovariectomy-Induced Osteoporosis
por: Lin, Xiao, et al.
Publicado: (2022)

Cyperenoic acid suppresses osteoclast differentiation and delays bone loss in a senile osteoporosis mouse model by inhibiting non-canonical NF-κB pathway
por: Chawalitpong, Supatta, et al.
Publicado: (2018)

The role of MicroRNAs in Osteoclasts and Osteoporosis
por: Tang, Peifu, et al.
Publicado: (2015)

Membrane trafficking in osteoclasts and implications for osteoporosis
por: Ng, Pei Ying, et al.
Publicado: (2019)

Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF‐κB pathway
por: Li, Yajun, et al.
Publicado: (2022)

Continuous decline in bone mineral density and deterioration of bone microarchitecture 7 years after Roux-en-Y gastric bypass surgery
por: Hansen, Stinus, et al.
Publicado: (2020)

Simulated Interventions to Ameliorate Age-Related Bone Loss Indicate the Importance of Timing
por: Proctor, Carole J., et al.
Publicado: (2016)

Cervical vertebrae for early bone loss evaluation in osteoporosis mouse models
por: Teng, Bin, et al.
Publicado: (2023)

Dysregulation of 5-hydroxytryptamine 6 receptor accelerates maturation of bone-resorbing osteoclasts and induces bone loss
por: Park, Kyung-Ran, et al.
Publicado: (2018)

Bone loss: Factors that regulate osteoclast differentiation - an update
por: Roux, Sophie, et al.
Publicado: (2000)

Schistosome infection promotes osteoclast-mediated bone loss
por: Li, Wei, et al.
Publicado: (2021)

Targeted Overexpression of Osteoactivin in Cells of Osteoclastic Lineage Promotes Osteoclastic Resorption and Bone Loss in Mice
por: Sheng, Matilda H.-C., et al.
Publicado: (2012)

Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis
por: Zhao, Xin, et al.
Publicado: (2021)

Reduced osteoclast-derived apoptotic bodies in bone marrow characterizes the pathological progression of osteoporosis
por: Wu, Yutong, et al.
Publicado: (2023)

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
por: Awida, Zamzam, et al.
Publicado: (2022)

Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss
por: Harre, Ulrike, et al.
Publicado: (2015)

P2X7 receptor knockdown suppresses osteoclast differentiation by inhibiting autophagy and Ca(2+)/calcineurin signaling
por: Ma, Yonggang, et al.
Publicado: (2022)

The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis
por: Da, Wacili, et al.
Publicado: (2021)

How zoledronic acid improves osteoporosis by acting on osteoclasts
por: Wang, Biao, et al.
Publicado: (2022)

Purinergic Signaling in Bone
por: Jørgensen, Niklas Rye, et al.
Publicado: (2013)

Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss
por: Stubelius, Alexandra, et al.
Publicado: (2016)

Suppression Effect of Astaxanthin on Osteoclast Formation In Vitro and Bone Loss In Vivo
por: Hwang, Yun-Ho, et al.
Publicado: (2018)

How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
por: Steffen, Ulrike, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p3n9ljbs9hc54om91k3qb0oso3